I think it is quite challenging for the FDA and for many reasons to stay as current as possible on those things which are simply just emerging.
Jason Smith: “I think it is quite challenging for the FDA and for many reasons to stay as current as possible on those things which…”
Editor's note · Context
Smith discusses the FDA's struggle to keep up with emerging technologies.
Share
More from Jason Smith
I rise in support of the Ending Improper Payments to Deceased People Act. This bipartisan bill continues a bipartisan policy that has already enabled the Federal Government to identify, prevent, and recover hundreds of millions of dollars…
Mr. Speaker, I rise in favor of the Supporting Pregnant and Parenting Women and Families Act led by Representative Fischbach. What this bill does is really pretty simple. It ensures States will be able to continue to use TANF funds for…
this is what this one big, beautiful bill is all about. This is what 77 million Americans voted for: make the 2017 Trump tax cuts permanent, no tax on tips, no tax on overtime, no tax on car loan interest, and tax relief for seniors. The…
Mr. Speaker, I think it is important to point out that 86,800 individuals in the district of the ranking member of the Tax Subcommittee, who was speaking before me, because of passage of this bill, those 86,800 families in California will…





